MA40034A - Manufacture and use of modern ovotransferrin (otf-m) - Google Patents

Manufacture and use of modern ovotransferrin (otf-m)

Info

Publication number
MA40034A
MA40034A MA040034A MA40034A MA40034A MA 40034 A MA40034 A MA 40034A MA 040034 A MA040034 A MA 040034A MA 40034 A MA40034 A MA 40034A MA 40034 A MA40034 A MA 40034A
Authority
MA
Morocco
Prior art keywords
ovotransferrin
otf
manufacture
purification
extracted
Prior art date
Application number
MA040034A
Other languages
French (fr)
Inventor
Constantin Chiurciu
Viorica Chiurciu
Mariana Oporanu
Lonel Victor Patrascu
Georgiana Topilescu
Original Assignee
Romvac Company Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Romvac Company Sa filed Critical Romvac Company Sa
Publication of MA40034A publication Critical patent/MA40034A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

This invention refers to the method of manufacture and purification of specific ovotransferrin also called modern ovotransferrin (otf-m) from the egg white, consisting of preparation of antigens, immunization of laying chickens with a certain antigen, purification and assessment of egg white-extracted otf-m. The specific ovotransferrin is extracted by a two-stage precipitation with various concentrations of ammonium sulfate and citric acid, followed by dialysis and freeze-drying. This invention also refers to the composition of antigens prepared from a mixture of antibiotic-resistant strains from a single species of bacteria or of an antigen prepared from a mixture of various antibiotic-resistant species of strains, isolated from patients in romania. This invention is susceptible for industrial use.
MA040034A 2014-08-28 2015-07-14 Manufacture and use of modern ovotransferrin (otf-m) MA40034A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ROA201400653A RO130063A8 (en) 2014-08-28 2014-08-28 Production and use of modern ovotransferrin ()

Publications (1)

Publication Number Publication Date
MA40034A true MA40034A (en) 2016-03-03

Family

ID=52544113

Family Applications (1)

Application Number Title Priority Date Filing Date
MA040034A MA40034A (en) 2014-08-28 2015-07-14 Manufacture and use of modern ovotransferrin (otf-m)

Country Status (4)

Country Link
EP (1) EP3307759A1 (en)
MA (1) MA40034A (en)
RO (1) RO130063A8 (en)
WO (1) WO2016032352A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO130418A8 (en) * 2015-01-13 2017-06-30 Romvac Company S.A. Production and utilization of ovotransferrin pc2 ()
RO132299A3 (en) * 2017-06-06 2018-12-28 Fântână Raul Sorin Composition and method for preparing and evaluating a complex immunogen named i-spga meant to produce immunologically active proteins

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3982040A (en) 1975-10-16 1976-09-21 The Procter & Gamble Company Egg white composition
JP3189773B2 (en) 1998-01-09 2001-07-16 三菱電機株式会社 Method of forming resist pattern, method of manufacturing semiconductor device using the same, and semiconductor device
KR100627680B1 (en) 2004-02-10 2006-09-25 유익종 Preparation method for heated liquified egg yolk without bitteness
JP4806655B2 (en) 2006-09-07 2011-11-02 キユーピー株式会社 Modified dried egg white and method for producing the same, and food containing modified dried egg white
US20080071067A1 (en) 2006-09-20 2008-03-20 Avigenics, Inc. Methods of purifying proteins from egg white
WO2008086431A1 (en) 2007-01-09 2008-07-17 Biova, L.L.C. A method of separating components of technical eggs, edible eggs, yolk and whites and products therefrom
BRPI0911667A2 (en) 2008-04-23 2019-04-24 Danisco Us Inc isoprene synthase variant for enhanced microbial isoprene production
CN102348387B (en) 2009-01-28 2014-12-31 让-保罗·佩罗丹 Method for production of lactoferrin
WO2012146717A1 (en) 2011-04-29 2012-11-01 Dsm Ip Assets B.V. Preparation of an egg white composition
TWI450727B (en) 2011-12-29 2014-09-01 Ind Tech Res Inst Single-domain anti-human transferrin receptor antibody and uses thereof
CN102584985A (en) 2012-03-09 2012-07-18 中国石油大学(华东) Method for extracting ovotransferrin from egg white
US20140072687A1 (en) 2012-09-07 2014-03-13 Annelouise Hemingway Apparatus and Methods for Separating an Egg Yolk from a Whole Egg

Also Published As

Publication number Publication date
EP3307759A1 (en) 2018-04-18
WO2016032352A1 (en) 2016-03-03
RO130063A0 (en) 2015-02-27
RO130063A8 (en) 2017-06-30

Similar Documents

Publication Publication Date Title
WO2018115507A3 (en) Henipavirus vaccine
EA201991157A1 (en) DELIVERY OF PROTEINS BASED ON BACTERIA ATTENUATED BY VIRULENCE
MX2018009917A (en) Zika virus vaccine.
PH12018500916A1 (en) Antibody neutralizing human respiratory syncytial virus
PH12015501558B1 (en) Human antibodies to respiratory syncytial virus f protein and methods of use thereof
MX2022005253A (en) Polyomavirus neutralizing antibodies.
EA032929B1 (en) Human immunodeficiency virus neutralizing antibody and methods of use thereof
UA116999C2 (en) Anti-hemagglutinin antibodies and methods of use
MX2017005642A (en) Anti-ang2 antibodies and methods of use.
EA201791907A1 (en) BIVALENT VACCINE AGAINST SWINE FLU VIRUS
EA201692279A1 (en) METHOD FOR REDUCING IMMUNOGENIC PROTEIN AND PEPTIDE
EA201890815A1 (en) AMINO ACID COMPOSITIONS WITH MODIFIED DELIVERY FOR ORAL ADMINISTRATION
CO2021014694A2 (en) A subunit vaccine for the treatment or prevention of a respiratory tract infection
EA201691915A1 (en) IMMUNOLOGICAL COMPOSITIONS, INCLUDING WEAKENED BY Histophilus somni
EA201300136A1 (en) DRUG AND METHOD OF PREVENTION OF HIV INFECTION, PREVENTION AND TREATMENT OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV, INCLUDING AIDS
EA201300132A1 (en) PHARMACEUTICAL COMPOSITION AND METHODS OF TREATMENT AND PREVENTION OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV
EA201891527A1 (en) COMPOSITIONS AND METHODS OF DETECTION AND TREATMENT OF CANCER ETHESIS
MX2019005751A (en) Treatment of respiratory tract diseases and infections with glutathione compositions.
EA201891528A1 (en) COMPOSITIONS AND METHODS OF DETECTION AND TREATMENT OF GASTRIC CANCER
NZ724772A (en) Antibodies against hpa-1a
MA40034A (en) Manufacture and use of modern ovotransferrin (otf-m)
IN2014DN05865A (en)
MX2018014532A (en) A method of reducing egg contamination.
GB2568440A (en) Modified factor H binding protein
BR112014016110A2 (en) tobacco leaf flattening method